CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 73 enrolled
Drug / intervention
Spinal Cord Stimulation (SCS) Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02741297
NCT02741297N/ACompleted

A Multi-Center Controlled Study to Characterize the Real-world Outcomes of High Rate Spinal Cord Stimulation Therapy Using Boston Scientific (BSC) PRECISION Spinal Cord Stimulator System

Boston Scientific Corporation·interventional·Posted Apr 18, 2016·Updated Jan 5, 2021

In Brief

A clinical study evaluating Spinal Cord Stimulation (SCS) System for Chronic Pain. Completed, enrolled 73 participants across 5 sites in 4 countries.

Detailed Summary

The primary objective of this study is to characterize the real-world outcomes of spinal cord stimulation (SCS) therapy as an aid in the management of chronic intractable pain of the trunk, including unilateral or bilateral pain associated with the following: failed back surgery syndrome, intractable low back pain using the Boston Scientific (BSC) PRECISION Spinal Cord Stimulator System with MultiWave Technology.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Pain
CountriesGermany, Italy, Netherlands, United Kingdom
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedApr 18, 2016
Enrollment StartApr 19, 2016
Primary CompletionSep 21, 2018
Study CompletionJun 25, 2019
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 10.2 years ago

Interventions

Spinal Cord Stimulation (SCS) Systemdevice

Boston Scientific (BSC) PRECISION SCS System with MultiWave Technology